Proposal concerning members of the Board

Supplement to the notice of the Annual General Meeting to be held on April 29, 2008

Vitrolife’s election committee has in the notice to attend the Annual General Meeting on March 28, 2008 proposed that the members of the Board shall be five or six in number, without any deputies, and that the Board shall consist of the following members: Patrik Tigerschiöld (re-election), Madeleine Olsson-Eriksson (re-election), Semmy Rülf (re-election), Fredrik Mattsson (re-election) and Maris Hartmanis (new election). A presentation of Maris Hartmanis was made in the notice to attend the Annual General Meeting.

The election committee proposes Tord Lendau as the sixth member of the Board. Tord Lendau was born in 1957 and is today managing director of product area MedTech within Sandvik. Tord has previously been the CEO of Artimplant AB and he has also worked in senior positions in, for example, Noster Systems AB and Medtronic/Synectics. Today he is also a member of the Board for Nasdaq-listed ArthroCare, Inc. Tord Lendau does not own any shares in Vitrolife.

The company has been informed that shareholders representing approximately 38 percent of the shares and votes in the company support the proposal of the election committee.


April 16, 2008
Kungsbacka, Sweden

The Board






Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.